-
3
-
-
80052412647
-
WHO classification of malignant lymphomas in Korea: Report of the third nationwide study
-
Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: Report of the third nationwide study. Korean J Pathol 2011;45:254-260.
-
(2011)
Korean J Pathol
, vol.45
, pp. 254-260
-
-
Kim, J.M.1
Ko, Y.H.2
Lee, S.S.3
-
4
-
-
0034598746
-
Distinct types of diff use large B-cell lymphoma identified by gene expression profiling
-
Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diff use large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
-
(2000)
Nature
, vol.403
, pp. 503-511
-
-
Alizadeh, A.A.1
Eisen, M.B.2
Davis, R.E.3
-
5
-
-
68549124173
-
A new immunostain algorithm classifies diff use large B-cell lymphoma into molecular subtypes with high accuracy
-
Choi WW,Weisenburger DD,Greiner TC, et al. A new immunostain algorithm classifies diff use large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009;15:5494-5502.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5494-5502
-
-
Choi, W.W.1
Weisenburger, D.D.2
Greiner, T.C.3
-
6
-
-
9144237554
-
Confirmation of the molecular classification of diff use large B-cell lymphoma by immunohistochemistry using a tissue microarray
-
Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diff use large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282.
-
(2004)
Blood
, vol.103
, pp. 275-282
-
-
Hans, C.P.1
Weisenburger, D.D.2
Greiner, T.C.3
-
7
-
-
79955944673
-
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diff use large B-cell lymphoma treated with immunochemotherapy
-
Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diff use large B-cell lymphoma treated with immunochemotherapy. Blood 2011;117:4836-4843.
-
(2011)
Blood
, vol.117
, pp. 4836-4843
-
-
Gutierrez-Garcia, G.1
Cardesa-Salzmann, T.2
Climent, F.3
-
8
-
-
0037217921
-
Clinical impact of the diff erentiation profile assessed by immunophenotyping in patients with diff use large B-cell lymphoma
-
Colomo L, Lopez-Guillermo A,Perales M, et al. Clinical impact of the diff erentiation profile assessed by immunophenotyping in patients with diff use large B-cell lymphoma. Blood 2003;101:78-84.
-
(2003)
Blood
, vol.101
, pp. 78-84
-
-
Colomo, L.1
Lopez-Guillermo, A.2
Perales, M.3
-
9
-
-
79951802728
-
A 20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
-
Hovelmeyer N, Reissig S, Xuan N T, et al. A 20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 2011;41:595-601.
-
(2011)
Eur J Immunol
, vol.41
, pp. 595-601
-
-
Hovelmeyer, N.1
Reissig, S.2
Xuan, N.T.3
-
10
-
-
79955956764
-
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
-
Giulino L, Mathew S, Ballon G, et al. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood 2011;117:4852-4854.
-
(2011)
Blood
, vol.117
, pp. 4852-4854
-
-
Giulino, L.1
Mathew, S.2
Ballon, G.3
-
11
-
-
80051561179
-
A20 regulation of nuclear factor-kappaB: Perspectives for inflammatory lung disease
-
Kelly C, Shields MD, Elborn JS, et al. A20 regulation of nuclear factor-kappaB: Perspectives for inflammatory lung disease. Am J Respir Cell Mol Biol 2011;44:743-748.
-
(2011)
Am J Respir Cell Mol Biol
, vol.44
, pp. 743-748
-
-
Kelly, C.1
Shields, M.D.2
Elborn, J.S.3
-
12
-
-
80052195163
-
A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
-
Matmati M, Jacques P, Maelfait J, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 2011;43:908-912.
-
(2011)
Nat Genet
, vol.43
, pp. 908-912
-
-
Matmati, M.1
Jacques, P.2
Maelfait, J.3
-
13
-
-
79952192654
-
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
-
Adrianto I, Wen F, Templeton A, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 2011;43:253-258.
-
(2011)
Nat Genet
, vol.43
, pp. 253-258
-
-
Adrianto, I.1
Wen, F.2
Templeton, A.3
-
14
-
-
77955504366
-
Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling
-
Huang H, Tang QZ, Wang AB, et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 2010;56:232-239.
-
(2010)
Hypertension
, vol.56
, pp. 232-239
-
-
Huang, H.1
Tang, Q.Z.2
Wang, A.B.3
-
15
-
-
79952762862
-
A20 modulates lipid metabolism and energy production to promote liver regeneration
-
Damrauer SM, Studer P, da Silva CG, et al. A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One 2011;6: E17715.
-
(2011)
PLoS One
, vol.6
-
-
Damrauer, S.M.1
Studer, P.2
Da Silva, C.G.3
-
16
-
-
66049124247
-
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
-
Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009;206:981-989.
-
(2009)
J Exp Med
, vol.206
, pp. 981-989
-
-
Schmitz, R.1
Hansmann, M.L.2
Bohle, V.3
-
18
-
-
0036668002
-
Chromosomal imbalances in diff use large B-cell lymphoma detected by comparative genomic hybridization
-
Berglund M, Enblad G, Flordal E, et al. Chromosomal imbalances in diff use large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 2002;15:807-816.
-
(2002)
Mod Pathol
, vol.15
, pp. 807-816
-
-
Berglund, M.1
Enblad, G.2
Flordal, E.3
-
19
-
-
4444365802
-
Clinicopathologic significance and prognostic value of chromosomal imbalances in diff use large B-cell lymphomas
-
Bea S, Colomo L, Lopez-Guillermo A, et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diff use large B-cell lymphomas. J Clin Oncol 2004;22:3498-3506.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3498-3506
-
-
Bea, S.1
Colomo, L.2
Lopez-Guillermo, A.3
-
20
-
-
70350504882
-
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
-
Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009;114:2467-2475.
-
(2009)
Blood
, vol.114
, pp. 2467-2475
-
-
Honma, K.1
Tsuzuki, S.2
Nakagawa, M.3
-
21
-
-
66649112854
-
Frequent inactivation of A20 in B-cell lymphomas
-
Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009;459:712-716.
-
(2009)
Nature
, vol.459
, pp. 712-716
-
-
Kato, M.1
Sanada, M.2
Kato, I.3
-
22
-
-
76749103364
-
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
-
Chanudet E, Huang Y, Ichimura K, et al. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 2010;24:483-487.
-
(2010)
Leukemia
, vol.24
, pp. 483-487
-
-
Chanudet, E.1
Huang, Y.2
Ichimura, K.3
-
23
-
-
80052431620
-
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome
-
Braun FC, Grabarczyk P, Mobs M, et al. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia 2011;25:1494-1501.
-
(2011)
Leukemia
, vol.25
, pp. 1494-1501
-
-
Braun, F.C.1
Grabarczyk, P.2
Mobs, M.3
-
24
-
-
79952730520
-
A20 ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diff use large B-cell lymphoma
-
Dong G, Chanudet E, Zeng N, et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diff use large B-cell lymphoma. Clin Cancer Res 2011;17:1440-1451.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1440-1451
-
-
Dong, G.1
Chanudet, E.2
Zeng, N.3
-
25
-
-
77951800247
-
Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders
-
Yoon SO,Kim WY,GoH, et al. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders. Am J Surg Pathol 2010;34:645-655.
-
(2010)
Am J Surg Pathol
, vol.34
, pp. 645-655
-
-
Yoon, S.O.1
Kim, W.Y.2
Go, H.3
-
26
-
-
47749103376
-
MYC translocation and an increased copy number predict poor prognosis in adult diff use large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
-
Yoon SO, Jeon YK, Paik JH, et al. MYC translocation and an increased copy number predict poor prognosis in adult diff use large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 2008;53:205-217.
-
(2008)
Histopathology
, vol.53
, pp. 205-217
-
-
Yoon, S.O.1
Jeon, Y.K.2
Paik, J.H.3
-
27
-
-
70349639243
-
Increased quantity of tumorinfiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
-
Kim WY, Jeon YK, Kim TM, et al. Increased quantity of tumorinfiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Ann Oncol 2009;20:1688-1696.
-
(2009)
Ann Oncol
, vol.20
, pp. 1688-1696
-
-
Kim, W.Y.1
Jeon, Y.K.2
Kim, T.M.3
-
28
-
-
80052892884
-
Th ymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue :A clinicopathological and genetic analysis of six cases
-
Go H, Cho HJ, Paik JH, et al. Th ymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue :A clinicopathological and genetic analysis of six cases. Leuk Lymphoma 2011;52:2276-2283.
-
(2011)
Leuk Lymphoma
, vol.52
, pp. 2276-2283
-
-
Go, H.1
Cho, H.J.2
Paik, J.H.3
-
29
-
-
0028919385
-
Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue
-
Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-2004.
-
(1995)
Blood
, vol.85
, pp. 2000-2004
-
-
Wotherspoon, A.C.1
Finn, T.M.2
Isaacson, P.G.3
-
30
-
-
84860347892
-
A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology
-
Hirsch B, Grunbaum M, Wagner F, et al. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology. Histopathology 2012;60:E19-E27.
-
(2012)
Histopathology
, vol.60
-
-
Hirsch, B.1
Grunbaum, M.2
Wagner, F.3
-
31
-
-
34447507710
-
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
-
Vendrell JA, Ghayad S, Ben-Larbi S, et al. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene 2007;26:4656-4667.
-
(2007)
Oncogene
, vol.26
, pp. 4656-4667
-
-
Vendrell, J.A.1
Ghayad, S.2
Ben-Larbi, S.3
-
32
-
-
77649100933
-
Targeting A20 decreases glioma stem cell survival and tumor growth
-
Hjelmeland AB, Wu Q, Wickman S, et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 2010;8: E1000319.
-
(2010)
PLoS Biol
, vol.8
-
-
Hjelmeland, A.B.1
Wu, Q.2
Wickman, S.3
-
33
-
-
0035067050
-
A 20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins
-
Lademann U, Kallunki T, Jäättelä M. A 20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins. Cell Death Differ 2001;8:265.
-
(2001)
Cell Death Differ
, vol.8
, pp. 265
-
-
Lademann, U.1
Kallunki, T.2
Jäättelä, M.3
-
34
-
-
84862819723
-
Targeting A20 enhances TRAILinduced apoptosis in hepatocellular carcinoma cells
-
Dong B, Lv G, Wang Q, et al. Targeting A20 enhances TRAILinduced apoptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2012;418:433-438.
-
(2012)
Biochem Biophys Res Commun
, vol.418
, pp. 433-438
-
-
Dong, B.1
Lv, G.2
Wang, Q.3
-
35
-
-
67650456585
-
A20 is overexpressed in glioma cells and may serve as a potential therapeutic target
-
Guo Q, Dong H, Liu X, et al. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target. Expert Opin Ther Targets 2009;13:733-741.
-
(2009)
Expert Opin Ther Targets
, vol.13
, pp. 733-741
-
-
Guo, Q.1
Dong, H.2
Liu, X.3
-
36
-
-
84856213846
-
The diverse and complex roles of NF-kappaB subunits in cancer
-
Perkins ND. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 2012;12:121-132.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 121-132
-
-
Perkins, N.D.1
-
37
-
-
34250365875
-
Genome-wide arraybased comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma
-
Kim WS, Honma K, Karnan S, et al. Genome-wide arraybased comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2007;46:776-783.
-
(2007)
Genes Chromosomes Cancer
, vol.46
, pp. 776-783
-
-
Kim, W.S.1
Honma, K.2
Karnan, S.3
-
38
-
-
36549072913
-
TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma
-
Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2008;47:1-7.
-
(2008)
Genes Chromosomes Cancer
, vol.47
, pp. 1-7
-
-
Honma, K.1
Tsuzuki, S.2
Nakagawa, M.3
-
40
-
-
12144289671
-
Building an outcome predictor model for diff use large B-cell lymphoma
-
Saez AI, Saez AJ, Artiga MJ, et al. Building an outcome predictor model for diff use large B-cell lymphoma. Am J Pathol 2004;164:613-622.
-
(2004)
Am J Pathol
, vol.164
, pp. 613-622
-
-
Saez, A.I.1
Saez, A.J.2
Artiga, M.J.3
-
41
-
-
1842529746
-
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diff use large B-cell lymphoma
-
Chang CC, McClintock S,Clevel and R P, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diff use large B-cell lymphoma. Am J Surg Pathol 2004;28:464-470.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 464-470
-
-
Chang, C.C.1
Sclevel, M.2
-
42
-
-
79960411409
-
Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma
-
De Mello CA, De Andrade VP, De Lima VC, et al. Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma. Leuk Lymphoma 2011;52:1495-1503.
-
(2011)
Leuk Lymphoma
, vol.52
, pp. 1495-1503
-
-
De Mello, C.A.1
De Andrade, V.P.2
De Lima, V.C.3
|